Cardioprotection of ramipril and BQ-123 against myocardial ischemia/reperfusion oxidative injury in vivo in rats

Chinese Pharmacological Bulletin

Volumn 25, Issue 12, 2009, Pages 1645-1649

  Huang, Zhuo Jun ^a   Wang, Yao ^a   Song, Jun Qiu ^a   Wu, Yan Na ^a   Liu, Yan Xia ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

BQ 123; Ischemia reperfusion; MDA; Myocardium; Ramipril; SOD

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; MALE; NONHUMAN; RAT; REPERFUSION INJURY; ST SEGMENT ELEVATION;

EID: 77649258321     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sandmann S, Li J, Fritzenkötter C, et al. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats [J]. Blood Press, 2006,15(2):116-28.
2. Song J Q, Liu Y X. Effect of ramipril on ischemia-reperfusion induced apoptosis of cardiomyocyte and expression of apoptosis-related genes [J]. Chin Pharmacol Bull, 2006,22(5):625-8.
3. Wu Y N, Zhang Z, Chen Y, et al. Study on cardioprotection of ramipril against ischemia/reperfusion injury in diabetic rats [J]. Chin Pharmacol Bull, 2008,24(7):924-8.
4. Climent B, Fernández N, García-Villalón A L, et al. Effects of antagonists for endothelin ET(A) and ET(B) receptors on coronary endothelial and myocardial function after ischemia-reperfusion in anesthetized goats [J]. Vascul Pharmacol, 2006,44(5):384-90.
5. Ozdemir R, Parlakpinar H, Polat A, et al. Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces bothmyocardial infarct size and oxidant injury [J]. Toxicol, 2006,219(1):142-9.
6. Böhm F, Beltran E, Pernow J. Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition [J]. J Intern Med, 2005,257(3):263-71.
7. Pollock D M. Endothelin, Angiotensin, and Oxidative Stress in Hypertension [J]. Hypertension, 2005,45(1):477-80.
8. Tzanidis A, Lim S, D. Hannan R, et al. Combined angiotensin and endothelin receptor blockade attenuates adverse cardiac remodeling post-myocardial infarction in the rat: Possible role of transforming growth factor β1 [J]. J Mol Cell Cardiol, 2001,33(1):969-81.
9. Tamareille S, Achour H, Amirian J, et al. Left ventricular unloading before reperfusion reduces endothelin-1 release and calcium overload in porcine myocardial infarction [J]. J Thorac Cardiovasc Surg, 2008,136(2): 343-51.
10. Yin H, Chao L, Chao J. Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion [J]. Life Sci, 2008,82(3-4):156-65.
11. Andreadou I, Iliodromitis E K, Farmakis D, Kremastinos D T. To prevent, protect and save the ischemic heart: antioxidants revisited [J]. Expert Opin Ther Targets, 2009,13(8):945-56.
12. Monassier J P. Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations [J]. Arch Cardiovasc Dis, 2008,101(7-8):491-500.
13. Lawler J M, Kwak H B, Kim J H, Suk M H. Exercise training inducibility of MnSOD protein expression and activity is retained while reducing prooxidant signaling in the heart of senescent rats [J]. Am J Physiol Regul Integr Comp Physiol, 2009,296(5):R1496-502.
14. French J P, Hamilton K L, Quindry J C, et al. Exercise-induced protection against myocardial apoptosis and necrosis: MnSOD, calcium-handling proteins, and calpain [J]. FASEB J, 2008,22(8):2862-71.